Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: doxorubicin|DRUG: epirubicin|DRUG: pirarubicin|DRUG: cyclophosphamide|DRUG: albumin-bound paclitaxel|DRUG: paclitaxel|DRUG: docetaxel
Sponsor: Chinese Academy of Medical Sciences
Collaborators: CSPC Ouyi Pharmaceutical Co., Ltd.